Unlocking a crucial piece of schizophrenia’s molecular puzzle, scientists at Northwell Health’s Feinstein Institutes for Medical Research have found that jumping genes, also known as transposable ...
A JAMA Psychiatry analysis estimates schizophrenia costs the U.S. $366.8B in 2024, with nearly 80% of costs driven by indirect, cross-system impacts. Schizophrenia’s economic burden spans healthcare, ...
The pathophysiology of schizophrenia increasingly implicates neurovascular dysfunction, notably disturbances of the blood–brain barrier (BBB) and the broader neurovascular unit. Endothelial cells, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results